Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study

Author(s):  Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana

Issue:  Mar/Apr 2023 - Volume 27, Number 2
View All Articles in Issue

Page(s):  108-112

Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Page 1
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Page 2
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Page 3
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Page 4
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Page 5

Download in electronic PDF format for $75

Abstract:  A postmenopausal female patient was suffering from vulvovaginal symptoms such as dryness and irritation, which were affecting her relationship with her partner and her overall quality of life. The patient was instructed to apply an estriol 0.1% vaginal ointment (PCCA Ellage Anhydrous Vaginal) for a duration of three months. The safety and efficacy of the compounded treatment were evaluated using an online data collection form, which included the validated Vulvovaginal Symptom Questionnaire. Post-treatment results show that the vulvovaginal symptoms were no longer bothersome, and that the patient’s relationship was no longer affected. There were no reports of undesirable effects as a result of the compounded treatment. This case study reinforces the benefits and convenience of using topical hormone replacement therapy in postmenopausal women.

Related Keywords: vulvovaginal symptoms, vulvar irritation, vaginal dryness, postmenopausal women, menopause, estrogen deficiency, chronic vaginal atrophy, dyspareunia, painful intercourse, sexual function, quality of life, relationships, estriol 0.1% vaginal ointment, topical preparation, topical hormone replacement therapy, intravaginal administration, Vulvovaginal Symptom Questionnaire, drug safety, formulations

Related Categories: FORMULATIONS, HRT, MENTAL HEALTH, CASE REPORTS, DOSAGE FORMS/DRUG CARRIERS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study
Lima Ramona
, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
Mar/Apr 2023
Pg. 108-112

Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1
Cutter Christopher B
Jan/Feb 2004
Pg. 16-21

The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women
Bramwell Bethany L
Nov/Dec 2010
Pg. 465-471

Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
Jul/Aug 2008
Pg. 295-304

Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2
Cutter Christopher B
Mar/Apr 2004
Pg. 96-99

Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome
Riepl Mike
Nov/Dec 2018
Pg. 456-465

A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2
Gillson George R
, Zava David T
Sep/Oct 2003
Pg. 330-338

Women's Oral Health: Is There a Hormonal Link?
Preckshot John
Jan/Feb 2004
Pg. 10-14

The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K
Jan/Feb 2013
Pg. 74-85

View Sample
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
Sep/Oct 2016
Pg. 359-364

Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454

Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy
Laque Larissa C
, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
Jan/Feb 2019
Pg. 77-81

Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Deleruyelle Laura J
Jan/Feb 2017
Pg. 6-16

Women's Health Book Reviews
Reed-Kane Dana
Sep/Oct 1999
Pg. 357-359

The Salivary Hormone Profile in the Clinical Evaluation of Women
Stephenson Kenna
Nov/Dec 2004
Pg. 427-435

Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women
Mason Dave
Jul/Aug 2002
Pg. 255-256

The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study
Ruiz Andres D
, Daniels Kelly R
Jan/Feb 2014
Pg. 70-77

Gentian Violet Vaginal Suppositories
Allen Loyd V Jr
Nov/Dec 2009
Pg. 556

Menopausal Women's Access Path to Bioidentical Hormone Replacement Therapy: An Exploratory Study
Moro Doris
, Young Wendy, Stein Richard, Isaac Winston, Goodman Deborah
Mar/Apr 2010
Pg. 165-170

Estradiol 0.1% Vaginal Solution
Allen Loyd V Jr
Sep/Oct 2008
Pg. 450

Return to Top